Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the interest coverage ratio high or low?
The interest coverage ratio of -47.89x is 26% above its 3-year average of -64.33x, near the high end of its 3-year range (-330.41x–-10.10x).
As of the fiscal period ended Sunday, March 31, 2024. 0.45% below its 12-month average of -47.67x.
Reported quarterly interest coverage; no daily interpolation. Q1 FY2024 (2024-03-31): -47.89x.
INTEREST COVERAGE RATIO
-47.89x
INTEREST COVERAGE RATIO AVG TTM
-47.67x
INTEREST COVERAGE RATIO AVG 3Y
-64.33x
INTEREST COVERAGE RATIO AVG 5Y
-64.33x
INTEREST COVERAGE RATIO AVG 10Y
-91.56x
INTEREST COVERAGE RATIO AVG 15Y
-91.56x
INTEREST COVERAGE RATIO AVG 20Y
-137.51x
CURRENT VS TTM AVG
-0.45%
CURRENT VS 3Y AVG
+25.56%
CURRENT VS 5Y AVG
+25.56%
CURRENT VS 10Y AVG
+47.69%
CURRENT VS 15Y AVG
+47.69%
CURRENT VS 20Y AVG
+65.17%
SECTOR MEDIAN · HEALTHCARE
-6.38x
median of 528 covered companies
CURRENT VS SECTOR MEDIAN
-651.19%
vs the sector median at left
ProMIS Neurosciences, Inc.
Market Cap
$82.59M
Interest Coverage Ratio
-47.89x
TTM Avg
-47.67x
3Y Avg
-64.33x
5Y Avg
-64.33x
Market Cap
$82.53M
Interest Coverage Ratio
N/A
TTM Avg
2.82x
3Y Avg
2.82x
5Y Avg
2.82x
Market Cap
$82.47M
Interest Coverage Ratio
N/A
TTM Avg
26.56x
3Y Avg
26.56x
5Y Avg
26.56x
Market Cap
$81.20M
Interest Coverage Ratio
-369.11x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$84.13M
Interest Coverage Ratio
-3676.85x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$79.61M
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | INTEREST COVERAGE RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| ProMIS Neurosciences, Inc. (PMN) | $82.59M | -47.89x | -47.67x | -64.33x | -64.33x |
| Telomir Pharmaceuticals, Inc. Common Stock (TELO)vs › | $82.53M | N/A | 2.82x | 2.82x | 2.82x |
| Cardiff Oncology, Inc. (CRDF)vs › | $82.47M | N/A | 26.56x | 26.56x | 26.56x |
| LENSAR Inc (LNSR)vs › | $82.29M | N/A | N/A | N/A | N/A |
| MediciNova, Inc. (MNOV)vs › | $81.22M | N/A | N/A | N/A | N/A |
| Nutriband Inc. (NTRB)vs › | $81.20M | -369.11x | N/A | N/A | N/A |
| Cognition Therapeutics, Inc. (CGTX)vs › | $84.13M | -3676.85x | N/A | N/A | N/A |
| Humacyte, Inc. (HUMA)vs › | $80.30M | -9.55x | N/A | N/A | N/A |
| Acrivon Therapeutics, Inc. Common Stock (ACRV)vs › | $79.61M | N/A | N/A | N/A | N/A |
| PMV Pharmaceuticals, Inc. (PMVP)vs › | $85.86M | N/A | N/A | N/A | N/A |
Interest Coverage
-47.9x
Debt/Equity
0.00
Current Ratio
7.85
Formula: Interest Coverage = EBIT / Interest Expense
Reference ranges:
Note: Interest coverage should be compared with historical interest expense, operating income, and industry capital structure.
Interest Coverage = EBIT / Interest Expense
The interest coverage ratio measures operating earnings relative to interest expense.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | INTEREST COVERAGE RATIO |
|---|---|
| 2024-03-31 | -47.89x |
| 2023-12-31 | -50.45x |
| 2023-09-30 | -33.38x |
| 2023-06-30 | -58.96x |
| 2022-06-30 | -36.22x |
| 2022-03-31 | -26.65x |
| 2021-12-31 | -34.58x |
| 2021-09-30 | -14.70x |
| 2021-06-30 | -10.10x |
| 2021-03-31 | -330.41x |
| 2017-09-30 | -886.19x |
| 2017-06-30 | -1012.76x |
| 2017-03-31 | -761.85x |
| 2016-12-31 | -203.73x |
| 2016-09-30 | -468.83x |
| 2016-06-30 | 47.42x |
| 2016-03-31 | 44.74x |
| 2015-12-31 | -170.11x |
| 2015-09-30 | -185.55x |
| 2015-06-30 | -26.31x |
| 2015-03-31 | -42.29x |
| 2013-03-31 | -11668.24x |
| 2005-06-30 | -340.33x |
